Anogen Pharma Private Limited
About Anogen Pharma Private Limited
Data last updated:
Anogen Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 06 December 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC326859. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi and Vikal Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Wz 31 35 Sq Yards G/F Back Side Portion Navyug Block Vishnu Garden Plot No. 28, New Delhi, Delhi, India – 110018.
As per the financials filed for FY 2025, the company reported a revenue of ₹18.51 Lakh, a growth of 62% compared to the previous year. For the same year it recorded a net loss of ₹93,030 (net margin -5%) and EBITDA of -₹84,751 (EBITDA margin -4.6%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 14% over five years.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Anogen Pharma Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressWz 31 35 Sq Yards G/F Back Side Portion Navyug Block Vishnu Garden Plot No. 28, New Delhi, Delhi, India – 110018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Anogen Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Anogen Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Anogen Pharma Private Limited, buy the company report.
Financials of Anogen Pharma Private Limited
FY 2025 filings availableAnogen Pharma Private Limited reported revenue of ₹18.51 Lakh (up 62% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 14% over five years, including 62% growth in the latest year. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹84,751 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹93,030 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.6% | ||||
| Net Profit Margin | -5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anogen Pharma Private Limited, buy the company report.
Board of directors of Anogen Pharma Private Limited
Anogen Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi | Director | 06 Dec 2017 | 8 Years 10 Months | Current |
| Vikal Kumar Also directs: Lifejack Pharma Private Limited | Director | 06 Dec 2017 | 8 Years 10 Months | Current |
Peer comparison
Anogen Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of chemicals and chemical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Saigaur Lifescience Private Limited | ₹19.4 Lakh (FY 2025) | -11.0% | Aurangabad, Maharashtra, India | |||
| Navchem Laboratories Private Limited | ₹19.29 Lakh (FY 2024) | -21.0% | Navi Mumbai, Maharashtra, India | |||
| Aaradhya Paints Private Limited | ₹18.79 Lakh (FY 2025) | -6.0% | Lucknow, Uttar Pradesh, India | |||
| Clean Science Private Limited | ₹18.76 Lakh (FY 2025) | 19.0% | Sangamner, Maharashtra, India | |||
| N Chemco (India) Private Limited | ₹18.61 Lakh (FY 2025) | 313.0% | Delhi, India | |||
| Anogen Pharma Private Limitedthis company | ₹18.51 Lakh (FY 2025) | -₹93,030 | -5% | 62.0% | New Delhi, Delhi, India | |
| Sigma Bond India Private Limited | ₹18.35 Lakh (FY 2025) | -58.0% | Bengaluru, Karnataka, India | |||
| Britacel Health Care Private Limited | ₹18.29 Lakh (FY 2025) | -6.0% | Mumbai, Maharashtra, India | |||
| Refab Enterprises Private Limited | ₹18.28 Lakh (FY 2025) | 91.0% | Noida, Uttar Pradesh, India | |||
| Rachna Agrochem Private Limited | ₹18 Lakh (FY 2024) | Thane, Maharashtra, India | ||||
| Indian Royale Private Limited | ₹18 Lakh (FY 2024) | 9.0% | New Delhi, Delhi, India |
To see the full peer comparison of Anogen Pharma Private Limited, buy the company report.
Auditor
Anogen Pharma Private Limited is audited by G V A P & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G V A P & ASSOCIATES | FY 2020 | 009009C |
Shareholding
The shareholding of Anogen Pharma Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Anogen Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Anogen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anogen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anogen Pharma has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Anogen Pharma Private Limited, buy the company report.
Recent activity
Anogen Pharma Private Limited has 2 board changes on record since 2017: 2 appointments. The latest: Ravi was appointed as Director on 06 Dec 2017.
Frequently asked questions
Anogen Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 06 December 2017 (9+ years old) and is registered under CIN U74999DL2017PTC326859.
Anogen Pharma has 2 current directors:
- Ravi - Director
- Vikal Kumar - Director
The latest financial statements of Anogen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
No. Anogen Pharma has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Anogen Pharma is U74999DL2017PTC326859. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anogen Pharma was incorporated on 06 December 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Anogen Pharma by revenue are Saigaur Lifescience Private Limited, Navchem Laboratories Private Limited, Aaradhya Paints Private Limited, Clean Science Private Limited, N Chemco (India) Private Limited and 5 more, all in the same principal business activity (manufacture of chemicals and chemical products).
Ravi was appointed as Director on 06 Dec 2017. Vikal Kumar was appointed as Director on 06 Dec 2017.
The registered office of Anogen Pharma is at Wz 31 35 Sq Yards GF Back Side Portion Navyug Block Vishnu Garden Plot No. 28, New Delhi, Delhi, India – 110018.
Anogen Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Anogen Pharma is active non-compliant as of 29 July 2026. The company is actively filing with the Registrar of Companies.